These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17167148)

  • 1. Heparin-induced thrombocytopenia.
    Saad RA
    N Engl J Med; 2006 Dec; 355(24):2598; author reply 2598-9. PubMed ID: 17167148
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations.
    Cho L; Kottke-Marchant K; Lincoff AM; Roffi M; Reginelli JP; Kaldus T; Moliterno DJ
    Am J Cardiol; 2003 May; 91(9):1110-3. PubMed ID: 12714157
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of ecarin chromogenic assay and prothrombinase induced clotting time in the monitoring of lepirudin for the treatment of heparin-induced thrombocytopenia.
    Guy S; Kitchen S; Laidlaw S; Cooper P; Woolley A; Maclean R
    Br J Haematol; 2008 Jul; 142(3):466-8. PubMed ID: 18510685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: a thrombus in the venous reservoir while using bivalirudin in a patient with heparin-induced thrombocytopenia undergoing heart transplantation.
    Wong JK; Tian Y; Shuttleworth P; Caffarelli AD; Reitz BA; Mora-Mangano CT
    Anesth Analg; 2010 Sep; 111(3):609-12. PubMed ID: 20686010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited commentary.
    Moten SC; Buxton B
    Ann Thorac Surg; 2005 Jul; 80(1):303. PubMed ID: 15975386
    [No Abstract]   [Full Text] [Related]  

  • 6. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bivalirudine in heparin-induced thrombocytopenia].
    Gasol-Boncompte M; Gracia-García B; Pastó-Cardona L; Jódar-Masanes R
    Farm Hosp; 2009; 33(5):285-6. PubMed ID: 19775579
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.
    Gordon G; Rastegar H; Schumann R; Deiss-Shrem J; Denman W
    J Cardiothorac Vasc Anesth; 2003 Oct; 17(5):632-5. PubMed ID: 14579220
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopenia.
    Gilmore JF; Adams CD; Blum RM; Fanikos J; Anne Hirning B; Matta L
    Am J Hematol; 2015 Aug; 90(8):E143-5. PubMed ID: 25913754
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin induced thrombocytopenia management with bivalirudin.
    Meera R; Rachel D; Ramakrishnapillai V; Vijayaraghavan G
    Indian Heart J; 2007; 59(4):354-5. PubMed ID: 19126942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant hirudin for extended aortic surgery in patients with heparin-induced thrombocytopenia.
    Bauer M; Koster A; Pasic M; Weng Y; Kuppe H; Hetzer R
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):191-2. PubMed ID: 10384203
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful use of hirudin during cardiac surgery using minimized extracorporeal circulation in patients with heparin-induced thrombocytopenia.
    Haneya A; Philipp A; Lehle K; Diez C; Rupprecht L; Kobuch R; Hirt SW; Zausig YA; Schmid C; Puehler T
    Ann Thorac Surg; 2011 Aug; 92(2):724-6. PubMed ID: 21801930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.
    Chamberlin JR; Lewis B; Leya F; Wallis D; Messmore H; Hoppensteadt D; Walenga JM; Moran S; Fareed J; McKiernan T
    Can J Cardiol; 1995 Jun; 11(6):511-4. PubMed ID: 7780873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia.
    Almond CS; Harrington J; Thiagarajan R; Duncan CN; LaPierre R; Halwick D; Blume ED; Del Nido PJ; Neufeld EJ; McGowan FX
    J Heart Lung Transplant; 2006 Nov; 25(11):1376-9. PubMed ID: 17097505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia.
    Clayton SB; Acsell JR; Crumbley AJ; Uber WE
    Ann Thorac Surg; 2004 Dec; 78(6):2167-9. PubMed ID: 15561064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal transplantation in a patient with catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia.
    Podolak B; Blickstein D; Inbal A; Eizner S; Rahamimov R; Yussim A; Mor E
    Isr Med Assoc J; 2014 Jan; 16(1):61-2. PubMed ID: 24575510
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of bivalirudin to treat heparin-induced thrombocytopenia in a patient with idiopathic giant-cell myocarditis.
    Alekshun TJ; Lundbye J; Sokol L; Dailey ME
    Conn Med; 2006 Feb; 70(2):69-71. PubMed ID: 16768056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invited commentary.
    Merry AF
    Ann Thorac Surg; 2007 Sep; 84(3):840. PubMed ID: 17720386
    [No Abstract]   [Full Text] [Related]  

  • 20. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.